Effect of Pimobendan or Benazepril Hydrochloride on Survival Times in Dogs with Congestive Heart Failure Caused by Naturally Occurring Myxomatous Mitral Valve Disease: The QUEST Study

Häggström, Jens; Boswood, Adrian; O'Grady, M.; Jöns, Olaf; Smith, Sarah; Swift, Simon; Borgarelli, Michele; GAVAGHAN, BJ; Kresken, Jan‐Gerd; Patteson, Mark; Åblad, B.; Bussadori, Claudio; M. Glaus, Tony; Kovačević, Alan; Rapp, Martin; A. Santilli, Roberto; Tidholm, Anna; Eriksson, Anders; Bélanger, Myriam; Deinert, Michael; Little, Christopher; Kvart, Clarence; French, Anne; Rønn‐Landbo, M.; Wess, Gerhard; Vigdís Eggertsdóttir, Anna; Lynne O’Sullivan, M.; Schneider, Matthias; Lombard, C; Dukes‐McEwan, Joanna; Willis, Ruth; Louvet, Arnaud; DiFruscia, Rocky

doi:10.1111/j.1939-1676.2008.0150.x

Public

Effect of Pimobendan or Benazepril Hydrochloride on Survival Times in Dogs with Congestive Heart Failure Caused by Naturally Occurring Myxomatous Mitral Valve Disease: The QUEST Study

Published in Journal of Veterinary Internal Medicine • Sep 1, 2008

Authors:

Jens Häggström

Adrian Boswood

M. O'Grady

Abstract

BACKGROUND: Myxomatous mitral valve disease (MMVD) continues to be an important cause of morbidity and mortality in geriatric dogs despite conventional therapy. HYPOTHESIS: Pimobendan in addition to conventional therapy will extend time to sudden cardiac death, euthanasia for cardiac reasons, or tre...

Subject

Medicine

Benazepril

Heart failure

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!